Pancreatic cancer risk: Associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort

被引:48
|
作者
Anderson, Kristin E. [1 ]
Mongin, Steven J. [2 ]
Sinha, Rashmi [3 ]
Stolzenberg-Solomon, Rachael [3 ]
Gross, Myron D. [4 ]
Ziegler, Regina G. [3 ]
Mabie, Jerome E. [5 ]
Risch, Adam [5 ]
Kazin, Sally S. [5 ]
Church, Timothy R. [2 ]
机构
[1] Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, Masonic Canc Ctr, Minneapolis, MN 55454 USA
[2] Univ Minnesota, Div Environm Hlth Sci, Sch Publ Hlth, Minneapolis, MN 55454 USA
[3] NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv,NIH, Rockville, MD USA
[4] Univ Minnesota, Sch Med, Minneapolis, MN 55454 USA
[5] Informat Management Serv Inc, Rockville, MD USA
基金
美国国家卫生研究院;
关键词
pancreatic cancer; carcinogens; cohort; meat intake; FOOD FREQUENCY QUESTIONNAIRE; HETEROCYCLIC AMINES; MUTAGENS; EXPOSURE; COOKING; MODULE;
D O I
10.1002/mc.20794
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Epidemiological studies report positive associations between high-temperature cooked meat intake and pancreatic cancer. We assessed associations between dietary intake of heterocyclic amines (HCAs) and benzo(a)pyrene (BaP)mutagens formed in meat cooked at high temperaturesand incident exocrine pancreatic cancer in a prospective cohort. Methods The 62 581 subjects randomized to screening in the Prostate, Lung, Colorectal, and Ovarian Screening Trial (PLCO) who completed an initial dietary survey that assessed meat intake, cooking methods, and doneness preferences defined the cohort. Subjects were surveyed annually for incident cancers through 2007. A National Cancer Institute research database (CHARRED) was used to estimate HCA and BaP intake and a Mutagenic Activity Index (MAI) from survey data. Proportional hazard ratios (HRs) for risk of pancreatic cancer were estimated from multi-variate Cox regression models by quintile of intake, with the lowest quintile as the referent. Results During follow-up (median: 10 yr), 248 cases of exocrine pancreatic cancer were confirmed. Preferences for well and very well done meat were generally associated with increased risks. Significant elevations in pancreatic cancer risk were found in upper quintiles of MAI, and individual mutagens 2-amino3,4,8- trimethylimidazo[ 4,5-f] quinoxaline (DiMeIQx) and 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx). Compared to the lowest quintile of MAI, the third and fifth quintiles brought HRs of 1.86 (1.22, 2.85) and 1.87 (1.16, 3.02), respectively. These three exposures exhibited significant (P-trend: 0.01-0.03) positive trends in risk as their levels increased Conclusion Consuming well-done meat cooked at high temperatures, which contains high mutagen levels, appears to confer increased risk of pancreatic cancer. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:128 / 137
页数:10
相关论文
共 50 条
  • [41] Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial
    Miller, Eric A.
    Pinsky, Paul F.
    Black, Amanda
    Andriole, Gerald L.
    Pierre-Victor, Dudith
    [J]. PROSTATE, 2018, 78 (11): : 830 - 838
  • [42] Measuring the impact of HIPAA in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
    Marcus, PM
    Miedzinksi, M
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) : 549 - 549
  • [43] Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Miller, AB
    Yurgalevitch, S
    Weissfeld, JL
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 400S - 406S
  • [44] The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource
    Zhu, Claire S.
    Huang, Wen-Yi
    Pinsky, Paulf F.
    Berg, Christine D.
    Sherman, Mark
    Yu, Kelly J.
    Carrick, Danielle M.
    Black, Amanda
    Hoover, Robert
    Lenz, Petra
    Williams, Craig
    Hawkins, Laura
    Chaloux, Matthew
    Yurgalevitch, Susan
    Mathew, Sunitha
    Miller, Amy
    Olivo, Vanessa
    Khan, Asia
    Pretzel, Shannon M.
    Multerer, Deborah
    Beckmann, Patricia
    Broski, Karen G.
    Freedman, Neal D.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (12) : 1635 - 1642
  • [45] Determinants of radical prostatectomy in the prostate, lung, colorectal, ovarian (PLCO) cancer screening trial
    Miller, David C.
    Church, Timothy R.
    Hickey, Thomas
    Greenlee, Robert T.
    Lzmirlian, Grant
    Mabie, Jerome
    Riley, Thomas L.
    Ragard, Lawrence
    Prorok, Philip C.
    Berg, Christine D.
    Crawford, E. David
    Andriole, Gerald L.
    Grubb, Robert L.
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 29 - 29
  • [46] Prediagnostic White Blood Cell DNA Methylation and Risk of Breast Cancer in the Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort
    Sturgeon, Susan R.
    Sela, David A.
    Browne, Eva P.
    Einson, Jonah
    Rani, Asha
    Halabi, Mohamed
    Kania, Thomas
    Keezer, Andrew
    Balasubramanian, Raji
    Ziegler, Regina G.
    Schairer, Catherine
    Kelsey, Karl T.
    Arcaro, Kathleen F.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (08) : 1575 - 1581
  • [47] Effectiveness of nurse endoscopists in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial
    Bresalier, RS
    Pinsky, P
    Weissfeld, J
    Schoen, R
    Church, T
    Yokochi, L
    Prorok, P
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A479 - A479
  • [48] Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial
    Trabert, Britton
    Eldridge, Ronald C.
    Pfeiffer, Ruth M.
    Shiels, Meredith S.
    Kemp, Troy J.
    Guillemette, Chantal
    Hartge, Patricia
    Sherman, Mark E.
    Brinton, Louise A.
    Black, Amanda
    Chaturvedi, Anil K.
    Hildesheim, Allan
    Berndt, Sonja I.
    Safaeian, Mahboobeh
    Pinto, Ligia
    Wentzensen, Nicolas
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (03) : 600 - 610
  • [49] Biomarkers of amino acid metabolism and endometrial cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    Michels, Kara A.
    Weinstein, Stephanie J.
    Wentzensen, Nicolas
    Pfeiffer, Ruth M.
    Trabert, Britton
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [50] Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Weissfeld, JL
    Fagerstrom, RM
    O'Brien, B
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 390S - 399S